Similar articles

• New technologies for biomarker discovery in multiple sclerosis.

  Comabella M, Racke MK. Comabella M, et al. J Neuroimmunol. 2012 Jul 15;248(1-2):1. doi: 10.1016/j.jneuroim.2012.05.018. J Neuroimmunol. 2012. PMID: 22726889 No abstract available.
• Beyond the blot: cutting edge tools for genomics, proteomics and metabolomics analyses and previous successes.

  Kimball AB, Grant RA, Wang F, Osborne R, Tiesman JP. Kimball AB, et al. Br J Dermatol. 2012 Jun;166 Suppl 2:1-8. doi: 10.1111/j.1365-2133.2012.10859.x. Br J Dermatol. 2012. PMID: 22670612 Review.
• 'Omics Approaches in Breast Cancer Research and Clinical Practice.

  Kalita-de Croft P, Al-Ejeh F, McCart Reed AE, Saunus JM, Lakhani SR. Kalita-de Croft P, et al. Adv Anat Pathol. 2016 Nov;23(6):356-367. doi: 10.1097/PAP.0000000000000128. Adv Anat Pathol. 2016. PMID: 27740960 Review.
• Recent Development in Omics Studies.

  Aizat WM, Ismail I, Noor NM. Aizat WM, et al. Adv Exp Med Biol. 2018;1102:1-9. doi: 10.1007/978-3-319-98758-3_1. Adv Exp Med Biol. 2018. PMID: 30382565 Review.
• The "omics" revolution and personalized medicine.

  Makhoul I. Makhoul I. J Ark Med Soc. 2012 Jun;108(13):288. J Ark Med Soc. 2012. PMID: 22799130 No abstract available.